Literature DB >> 10833099

The detection of cytokeratins in lymph nodes of Duke's B colorectal cancer subjects predicts a poor outcome.

G Clarke1, E Ryan, J C O'Keane, J Crowe, P MacMathuna.   

Abstract

OBJECTIVES: The objectives of this study were to examine the frequency of lymph node micrometastases detected by keratin immunohistochemistry and their relationship with survival behaviour.
METHODS: A total of 133 consecutive patients staged as Duke's B, who had curative resection for colorectal cancer (CRC), comprised the study population. Patients who had died of a non-CRC-related cause or who became lost to follow-up were excluded, resulting in an amended population of 100. Study end-points were defined as disease-free survival of 5 years or CRC-related death. Paraffin-embedded lymph node sections were stained with a commercial cytokeratin antibody using a standard avidin-biotin technique.
RESULTS: One quarter of subjects had micrometastases. Fifty-six per cent of subjects with positive lymph nodes had an adverse outcome, compared with 11% of subjects with negative nodes. A highly significant association was found between lymph node cytokeratin expression and mortality in both the univariate (log rank P = 0.0001) and multivariate (Cox proportional hazards P = 0.0123) analysis.
CONCLUSIONS: Lymph node micrometastases detected by this inexpensive and simple technique are significantly associated with mortality in Duke's B CRC. This technique may be used to select patients for adjuvant chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10833099     DOI: 10.1097/00042737-200012050-00012

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  11 in total

Review 1.  Nodal staging of colorectal carcinomas and sentinel nodes.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2003-05       Impact factor: 3.411

2.  Entire-volume serial histological examination for detection of micrometastases in lymph nodes of colorectal cancers.

Authors:  Masaki Hata; Junji Machi; Jonathan Mamou; Eugene T Yanagihara; Emi Saegusa-Beecroft; Gregory K Kobayashi; Clifford C M Wong; Conway Fung; Ernest J Feleppa; Kazuhiro Sakamoto
Journal:  Pathol Oncol Res       Date:  2011-04-15       Impact factor: 3.201

Review 3.  Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature.

Authors:  Daniel G Nicastri; John T Doucette; Tony E Godfrey; Steven J Hughes
Journal:  J Mol Diagn       Date:  2007-10-04       Impact factor: 5.568

4.  High prevalence of isolated tumour cells in regional lymph nodes from pN0 colorectal cancer.

Authors:  C Mescoli; M Rugge; S Pucciarelli; V M Russo; G Pennelli; M Guido; D Nitti
Journal:  J Clin Pathol       Date:  2006-04-07       Impact factor: 3.411

5.  Significance of the immunohistochemical detection of lymph node micrometastases in stage II colorectal carcinoma.

Authors:  José A García-Sáenz; María C Sáenz; Lucía González; Pedro Pérez-Segura; Javier Puente; Sara López-Tarruella; Javier Sastre; Antonio Casado; José G López-Asenjo; Eduardo Díaz-Rubio
Journal:  Clin Transl Oncol       Date:  2006-09       Impact factor: 3.405

6.  Tumor micrometastases in mesorectal lymph nodes and their clinical significance in patients with rectal caner.

Authors:  Yang-Chun Zheng; Yu-Ying Tang; Zong-Guang Zhou; Li Li; Tian-Cai Wang; Yi-Ling Deng; Dai-Yun Chen; Wei-Ping Liu
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

Review 7.  Sentinel lymph node biopsy progress in surgical treatment of cancer.

Authors:  T Schulze; A Bembenek; P M Schlag
Journal:  Langenbecks Arch Surg       Date:  2004-06-09       Impact factor: 3.445

Review 8.  Assessment of lymph node involvement in colorectal cancer.

Authors:  Mark L H Ong; John B Schofield
Journal:  World J Gastrointest Surg       Date:  2016-03-27

9.  Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer.

Authors:  Robert Rosenberg; Jan Friederichs; Ralf Gertler; Axel Hoos; James Mueller; Jorg Nahrig; Hjalmar Nekarda; Joerg-Ruediger Siewert
Journal:  Int J Colorectal Dis       Date:  2004-01-10       Impact factor: 2.571

10.  Does immunostaining effectively upstage colorectal cancer by identifying micrometastatic nodal disease?

Authors:  Khaled M Madbouly; Anthony J Senagore; Abir Mukerjee; Conor P Delaney; Jason Connor; Victor W Fazio
Journal:  Int J Colorectal Dis       Date:  2006-03-10       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.